Waters Corporation WAT

Revenue Intelligence Report • 70 quarters of SEC filing data • Updated 2026-03-15

Waters Corporation has a forecasted full-year revenue of $3.4B, a +7.2% year-over-year change, based on 70 quarters of SEC filing data. Key revenue drivers include R&D ($13.12 per $1) and SG&A ($3.42 per $1). The ARDL model achieves strong accuracy at 2.7% MAPE.

Investment Thesis

Our ARDL model tracks Waters Corporation's revenue with exceptional precision (2.7% MAPE), indicating highly predictable cash flows. Every $1 of R&D investment is associated with $13.12 of revenue, indicating efficient capital deployment in innovation. Each $1 of SG&A spending generates $3.42 in revenue, reflecting strong commercial efficiency.

Next FY Revenue
$3.39B
+7.2% YoY
R&D Multiplier
$13.12 per $1
SG&A Multiplier
$3.42 per $1
Model Accuracy
2.7% MAPE
Holdout validation: The model predicted $1.0B vs the actual $0.9B — an error of 4.4%.

Revenue Forecast

WAT Revenue Forecast

Quarterly Detail

QuarterModel ForecastActual95% RangeYoY GrowthStatus
Q4 2025 $1.0B $0.9B $0.9B – $1.0B +11.6% ✓ In range
Q1 2026 $0.8B $0.7B – $0.8B +15.5%
Q2 2026 $0.8B $0.7B – $0.9B +2.9%
Q3 2026 $0.8B $0.7B – $0.9B +1.3%
Q4 2026 $1.0B $0.9B – $1.1B +9.9%

Seasonal Factors

Multiplicative seasonal adjustment: These factors capture Waters Corporation's systematic quarterly revenue patterns relative to the trend model. A factor of 1.05 means that quarter typically runs 5% above the underlying trend; 0.95 means 5% below. Factors are computed as the median of (actual / fitted) across all available quarters.
Fiscal QuarterSeasonal Factorvs TrendInterpretationObs.
FQ1 (Sep–Nov) 1.0157 +1.6% In line with trend 17
FQ2 (Dec–Feb) 0.9994 -0.1% In line with trend 17
FQ3 (Mar–May) 0.974 -2.6% In line with trend 16
FQ4 (Jun–Aug) 1.0004 +0.0% In line with trend 16

How Spending Drives Revenue

WAT Spending Timing
Reading this chart: Each line shows the cumulative revenue generated per $1 spent over subsequent quarters. The effect builds over 4-5 quarters as investments mature.

Want this analysis for your portfolio?

I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.

Get in Touch

More in Healthcare

LLY PFE RMD BIIB WST COO ABBV IQV